Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Bristol-Myers Squibb patents MGAT2 inhibitors

Sep. 23, 2015

Clinical outcomes reported for triheptanoin in rare metabolic disorders

Sep. 23, 2015

SOFIA transgenic pig enables study of insulin secretory granule processing

Sep. 23, 2015

Taro launches Keveyis for primary hyperkalemic and hypokalemic periodic paralysis

Sep. 22, 2015

Clinical effect of K-877 may be superior to fibrate drugs on the market

Sep. 22, 2015

Saniona reports data supporting the use of Tesomet in type 2 diabetes, plans proof-of-concept study

Sep. 22, 2015

Palatin Technologies and Richter terminate license agreement for bremelanotide

Sep. 22, 2015

Transgenic pigs used to model gestational diabetes

Sep. 22, 2015

Glycemic improvements similar with omarigliptin and sitagliptin in patients with type 2 diabetes

Sep. 22, 2015

Bristol-Myers Squibb presents MGAT2 inhibitors

Sep. 21, 2015

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...